* Tectonic Therapeutic Inc is expected to show no change in quarterly revenue when it reports results on November 7 (estimated) for the period ending January 1 0001
*
* LSEG's mean analyst estimate for Tectonic Therapeutic Inc is for a loss of 82 cents per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Tectonic Therapeutic Inc is $55.00, above its last closing price of $43.02.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2024 -1.40 -1.50 -4.34 Missed -189.3
Mar. 31 2024 -4.32 -4.32 -1.80 Beat 58.3
Jan. 1 0001 -4.95 -4.04 -2.40 Beat 40.6
Sep. 30 2023 -3.34 -3.40 -5.28 Missed -55.3
Jun. -2.48 -0.90 -4.44 Missed -395
30 2023
Mar. 31 2023 -6.50 -6.54 -6.84 Missed -4.6
Dec. 31 2022 -5.91 -6.84 Missed -15.7
Sep. 30 2022 -6.82 -6.60 -6.24 Beat 5.5
This summary was machine generated November 6 at 04:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)